← Open Payments lookup

CARLOS AVILA: Open Payments

NPI 1740921030 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$511 in 14 payments from 10 companies in 2025. Trend: 2023 $332 · 2024 $574 · 2025 $511

Food & beverage: $511
CompanyPaymentsAmount
SCPHARMACEUTICALS INC.1$125
Phathom Pharmaceuticals, Inc.1$121
Novo Nordisk Inc4$83
Bayer Healthcare Pharmaceuticals Inc.2$38
Teva Pharmaceuticals USA, Inc.1$27
Lilly USA, LLC1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Boston Scientific Corporation1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
AstraZeneca Pharmaceuticals LP1$18

Products named: FUROSCIX, VOQUEZNA, Ozempic, Kerendia, AUSTEDO XR, MOUNJARO, Rybelsus, CAPLYTA.

Industry payments across TX — which companies pay providers there.